russ2000_2_0028|ALLO|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
russ2000_2_0028|ALLO|Long Name|Allogene Therapeutics Inc Total Current Assets (Quarterly) (USD)|Allogene Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Allogene Therapeutics Inc Inventories (Quarterly) (USD)|Allogene Therapeutics Inc Net PP&E (Quarterly) (USD)|Allogene Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Allogene Therapeutics Inc Total Liabilities (Quarterly) (USD)|Allogene Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Allogene Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Allogene Therapeutics Inc Total Deposits (Quarterly) (USD)|Allogene Therapeutics Inc Book Value (Quarterly) (USD)|Allogene Therapeutics Inc Retained Earnings (Quarterly) (USD)|Allogene Therapeutics Inc Treasury Stock (Quarterly) (USD)|Allogene Therapeutics Inc EV to Revenues|Allogene Therapeutics Inc EV to Earnings|Allogene Therapeutics Inc EV to Free Cash Flow|Allogene Therapeutics Inc EV to Assets (Quarterly)|Allogene Therapeutics Inc PS Ratio|Allogene Therapeutics Inc PE Ratio|Allogene Therapeutics Inc Price to Book Value|Allogene Therapeutics Inc PEG Ratio|Allogene Therapeutics Inc Debt to Equity Ratio|Allogene Therapeutics Inc Dividend Yield|Allogene Therapeutics Inc Shareholder Yield (TTM)|Allogene Therapeutics Inc Percent of Shares Outstanding Short|Allogene Therapeutics Inc Total Receivables (Quarterly) (USD)|Allogene Therapeutics Inc Total Payables (Quarterly) (USD)|Allogene Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Allogene Therapeutics Inc Return on Invested Capital|Allogene Therapeutics Inc Quality Ratio Score|Allogene Therapeutics Inc Momentum Score|Allogene Therapeutics Inc Beta (1Y)|Allogene Therapeutics Inc Sustainable Growth Rate (TTM)|Allogene Therapeutics Inc Institutional Investor Ownership Percentage|Allogene Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Allogene Therapeutics Inc Total Employees (Annual)|Allogene Therapeutics Inc EPS Diluted (Quarterly) (USD)|Allogene Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Allogene Therapeutics Inc Revenue (Quarterly) (USD)|Allogene Therapeutics Inc Gross Profit (Quarterly) (USD)|Allogene Therapeutics Inc SG&A Expense (Quarterly) (USD)|Allogene Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Allogene Therapeutics Inc Net Income (Quarterly) (USD)|Allogene Therapeutics Inc Net Interest Income (Quarterly) (USD)|Allogene Therapeutics Inc Price (USD)|Allogene Therapeutics Inc Total Return Price (USD)|Allogene Therapeutics Inc Enterprise Value (USD)|Allogene Therapeutics Inc 30-Day Average Daily Volume|Allogene Therapeutics Inc 1 Year Price Returns (Daily)||
russ2000_2_0028|ALLO|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
russ2000_2_0028|ALLO|201712|||||||||||||||||||||||||||||||||||78|||||||||||||||
russ2000_2_0028|ALLO|201803||||||||||||||||||||||||||||||||||44.0113||-0.059||||2.597|-2.597|-2.597|0|||||||
russ2000_2_0028|ALLO|201806|294.264|293.927||3.526|1.055|17.233|14.745|2.488||281.612|-137.522|||||||||||||||1.268|0.089|||||||113.689||-1.1866||||12.526|-134.902|-134.902|0.11|||||||
russ2000_2_0028|ALLO|201809|247.353|244.221||29.689|0.904|603.678|159.477|444.201||-168.443|-181.019|||||||||||||||3.083|0.031|||||||113.689|90|-0.3826||||11.317|-43.497|-43.497|-1.895||||||25|25
russ2000_2_0028|ALLO|201812|467.982|459.384||41.61|0.754|70.691|29.459|41.232||703.164|-211.528||||-62.9777||||4.6526|||0||7.0053|3.108|12.338|0.121|||||||121.4827|122|-0.37||||14.542|-30.626|-30.509|4.216|26.93|26.93|2812.1451|587235.5667||27.56|27.56
russ2000_2_0028|ALLO|201903|476.627|466.14||52.82|0.603|68.141|27.265|40.876||681.228|-243.114||||-68.3934||||4.9965|||0||8.067|3.391|12.976|0.121|||||||97.3159||-0.32||||13.058|-31.636|-31.586|4.825|28.91|28.91|3053.9702|514249||28.73|28.73
russ2000_2_0028|ALLO|201906|511.542|502.424||67.697|0.452|78.362|38|40.362||655.635|-284.357||||-31.5813||||4.7904|||0||9.6941|3.285|23.503|0.122|||||||99.8469|174|-0.41||||14.187|-41.402|-41.243|4.559|26.85|26.85|2797.1902|571470||28.34|28.34
russ2000_2_0028|ALLO|201909|509.757|501.244||77.38|0.301|75.828|33.354|42.474||619.716|-335.092||||-19.2477||||5.3609|||0||10.3757|2.337|8.047|0.122|||||||102.1866|190|-0.5||||15.016|-50.702|-50.735|4.309|27.255|27.255|2821.0179|421050.9667||27.44|27.44
russ2000_2_0028|ALLO|201912|544.576|530.533||100.944|0.151|88.779|33.079|55.7||629.023|-396.122||||-14.34||||5.1325|||0||10.324|2.403|9.25|0.124|||4|1.5025|||104.8416|206|-0.58||||15.212|-61.185|-61.03|3.658|25.98|25.98|2697.9341|759471.1333|-3.5277|26.22|26.22
russ2000_2_0028|ALLO|202003|504.414|492.923||110.185|0|82.004|26.818|55.186||606.519|-450.602||||-9.6855||||4.0149|||0||10.5404||7.199|0.125|||4|0.7424|||108.9635||-0.5||||15.641|-54.48|-54.48|3.261|19.44|19.44|1942.18|824548.3333|-32.7568|18.39|18.39
russ2000_2_0028|ALLO|202006|909.577|899.65||127.037|0|95.125|40.895|54.23||1163.419|-511.576||||-24.0432||||5.1245|||0||9.6385||9.057|0.139|||10|2.3295|||115.3772||-0.53||||15.862|-60.974|-60.974|2.34|42.82|42.82|5062.3242|1311107.0333|59.4786|42.62|42.62
russ2000_2_0028|ALLO|202009|||||||||||||||-20.6745||||4.5149|||0||7.4383||||||8|1.6145|||||||||||||37.71|37.71|4353.0325|594902.9667|38.3599|37.56|37.56